Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Amanda Jane Blanchard has worked on the following 15 EPO patent applications which have been published in the last five years:

EP12761789

NEUTRALISING ANTIBODIES TO THE MAJOR EXOTOXINS TCDA AND TCDB OF CLOSTRIDIUM DIFFICILE

IPC classification:
A61K 39/40, A61P 31/04, C07K 16/12
Applicant:
UCB Pharma S.A.
Applicant:
UCB Biopharma SPRL
Agent:
Amanda Jane Blanchard, UCB Celltech
Agent:
Bernadette Angelina Hambleton, Sterling IP
Status:
EXAMINATION IN PROGRESS
EP13725298

ANTI-FCRN ANTIBODIES

IPC classification:
C07K 16/28, G01N 33/53
Applicant:
UCB Pharma S.A.
Applicant:
UCB Biopharma SPRL
Agent:
Amanda Jane Blanchard, UCB Celltech
Status:
EXAMINATION IN PROGRESS
EP13723086

RECOMBINANT BACTERIAL HOST CELL FOR PROTEIN EXPRESSION

IPC classification:
C07K 16/24, C12N 15/70
Applicant:
UCB Pharma S.A.
Applicant:
UCB Biopharma SPRL
Agent:
Amanda Jane Blanchard, UCB Celltech
Status:
EXAMINATION IN PROGRESS
EP13732203

A METHOD FOR IDENTIFYING COMPOUNDS OF THERAPEUTIC INTEREST

IPC classification:
C07K 16/42, G01N 33/542
Applicant:
UCB Pharma S.A.
Applicant:
UCB Biopharma SPRL
Agent:
Amanda Jane Blanchard, UCB Celltech
Status:
EXAMINATION IN PROGRESS
EP12700417

LIPOCALIN 2 AS A BIOMARKER FOR IL-17 INHIBITOR THERAPY EFFICACY

IPC classification:
G01N 33/564, G01N 33/68
Applicant:
UCB Pharma S.A.
Applicant:
UCB Biopharma SPRL
Agent:
Amanda Jane Blanchard, UCB Celltech
Status:
EXAMINATION IN PROGRESS
EP11730048

DISULFIDE STABILIZED DVD-LG MOLECULES

IPC classification:
C07K 16/46
Applicant:
UCB Pharma S.A.
Applicant:
UCB Biopharma SPRL
Agent:
Amanda Jane Blanchard, UCB Celltech
Agent:
Bernadette Angelina Hambleton, Sterling IP
Status:
EXAMINATION IN PROGRESS
EP12183573

Dual specificity antibody fusions

IPC classification:
C07K 16/00, C07K 16/18, C07K 16/24, C07K 16/46
Applicant:
UCB Pharma S.A.
Applicant:
UCB Biopharma SPRL
Agent:
Amanda Jane Blanchard, UCB Celltech
Status:
EXAMINATION IN PROGRESS
EP13771131

METHODS FOR PRODUCING RECOMBINANT PROTEINS

IPC classification:
C12N 9/12, C12N 15/10, C12N 15/63
Applicant:
UCB Biopharma SPRL
Agent:
Amanda Jane Blanchard, UCB Celltech
Status:
EXAMINATION IN PROGRESS
EP13815506

SINGLE LINKER FABFV ANTIBODIES AND METHODS OF PRODUCING SAME

IPC classification:
C07K 16/18, C07K 16/28, C07K 16/46
Applicant:
UCB Biopharma SPRL
Agent:
Amanda Jane Blanchard, UCB Celltech
Status:
GRANT OF PATENT INTENDED
EP15190901

SINGLE CHAIN FC POLYPEPTIDES

IPC classification:
C07K 16/00
Applicant:
UCB Biopharma SPRL
Agent:
Amanda Jane Blanchard, UCB Celltech
Agent:
Bernadette Angelina Hambleton, Sterling IP
Status:
EXAMINATION REQUESTED
EP14731259

BLOCK DECOYS

IPC classification:
C12N 15/113
Applicant:
UCB Biopharma SPRL
Agent:
Amanda Jane Blanchard, UCB Celltech
Status:
EXAMINATION IN PROGRESS
EP12174216

Method for the treatment of glomerulonephritis

IPC classification:
A61P 13/12, C07K 16/24, C07K 16/28
Applicant:
UCB Pharma S.A.
Agent:
Christof Bull, UCB Pharma S.A.
Agent:
Amanda Jane Blanchard, UCB Celltech
Agent:
Carmen Jungen, UCB Pharma GmbH
Status:
PATENT GRANTED
EP12183571

Dual specificity antibody fusions

IPC classification:
C07K 16/00, C07K 16/18, C07K 16/24, C07K 16/46
Applicant:
UCB Pharma S.A.
Applicant:
UCB Biopharma SPRL
Agent:
Amanda Jane Blanchard, UCB Celltech
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12700433

ANTIBODY BINDING IL-17A AND IL-17F

IPC classification:
C07K 16/24
Applicant:
UCB Pharma S.A.
Applicant:
UCB Biopharma SPRL
Agent:
Amanda Jane Blanchard, UCB Celltech
Status:
PATENT GRANTED
EP11700101

THREEVALENT ANTIBODIES

IPC classification:
C07K 16/18, C07K 16/24, C07K 16/28, C07K 16/46
Applicant:
UCB Pharma S.A.
Applicant:
UCB Biopharma SPRL
Agent:
Amanda Jane Blanchard, UCB Celltech
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature